Advertisement
Advertisement
NKTR
Nektar Therapeutics
38.55
USDSponsored
+0.58
+1.53%
Oct 28, 15:59 UTC -4
Closed
After-Market
38.50
-0.05
-0.13%
Nektar Therapeutics (NKTR)
Nektar Therapeutics Financial Snapshot
| Market Cap | 1.31B |
| Beta | -- |
| Earnings Per Share (EPS) | -6.70 |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | 10.42% |
| Free Cash Flow | -120.18M |
